Are we getting closer to understanding why we get prostate cancer?

Every so often we note that we still have little to no really clear idea why men get prostate cancer in the first place (or indeed why any of us get any type of cancer). In this context, some new research from a team at the University of California, Los Angeles, is at least interesting. … READ MORE …

HHV8 infection NOT associated with risk for prostate cancer

Over the years there have been many suggestions that prostate cancer may be “caused” by one or more viral or bacterial infections. … READ MORE …

GDF-15, vitamin D, and risk for prostate cancer

A new study by Lambert et al. in the journal Prostate proposes that some forms of chronic prostatic inflammation, driven by low levels of a molecule known as growth differentiation factor-15 (GDF-15), may lead to prostate cancer development. … READ MORE …

Does prostatic inflammation increase risk for prostate cancer?

A new paper just published in Cancer, and based on information from patients gathered during the REDUCE study has suggested that men who have acute and/or chronic inflammation of the prostate on biopsy are actually at reduced risk for prostate cancer. … READ MORE …

Does prostatic inflammation lead to later prostate cancer?

A question that comes up all the time is whether there is any direct (i.e., cause and effect) association between prostate “inflammation” and a subsequent diagnosis of prostate cancer. … READ MORE …

Inflammation, biomarkers, and risk for prostate cancer

Whether there is any real association (let alone a cause and effect correlation) between clinically evident or subclinical inflammatory disorders and risk for prostate cancer is still not known — although long suspected. … READ MORE …

No clinical evidence that NSAIDs help to prevent prostate cancer

Data gathered as part of the ongoing ProtecT study in the United Kingdom provides no evidence that regular use of non-steroidal anti-inflammatory drugs l(NSAIDs) lowers risk for prostate cancer. … READ MORE …